BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35178768)

  • 1. Value of a café-au-lait macules screening clinic: Experience from The Hospital for Sick Children in Toronto.
    Albaghdadi M; Berseneva M; Pennal A; Wan S; Matviychuk D; Shugar A; Kannu P; Lara-Corrales I
    Pediatr Dermatol; 2022 Mar; 39(2):205-210. PubMed ID: 35178768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules.
    Ben-Shachar S; Dubov T; Toledano-Alhadef H; Mashiah J; Sprecher E; Constantini S; Leshno M; Messiaen LM
    J Am Acad Dermatol; 2017 Jun; 76(6):1077-1083.e3. PubMed ID: 28318682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated Approach to Patients with Multiple Café au Lait Macules.
    Albaghdadi M; Thibodeau ML; Lara-Corrales I
    Dermatol Clin; 2022 Jan; 40(1):9-23. PubMed ID: 34799039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of multiple café-au-lait macules for neurofibromatosis 1 in Chinese children.
    Yao R; Wang L; Yu Y; Wang J; Shen Y
    J Dermatol; 2016 May; 43(5):537-42. PubMed ID: 26458495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational spectrum by phenotype: panel-based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café-au-lait macules.
    Castellanos E; Rosas I; Negro A; Gel B; Alibés A; Baena N; Pineda M; Pi G; Pintos G; Salvador H; Lázaro C; Blanco I; Vilageliu L; Brems H; Grinberg D; Legius E; Serra E
    Clin Genet; 2020 Feb; 97(2):264-275. PubMed ID: 31573083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic variability among café-au-lait macules in neurofibromatosis type 1.
    Boyd KP; Gao L; Feng R; Beasley M; Messiaen L; Korf BR; Theos A
    J Am Acad Dermatol; 2010 Sep; 63(3):440-7. PubMed ID: 20605257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Café au Lait Macules and Associated Genetic Syndromes.
    Anderson S
    J Pediatr Health Care; 2020; 34(1):71-81. PubMed ID: 31831114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: Gene mutation analysis and skin imaging of isolated café-au-lait macules.
    Zhong Z; Yang T; Liu S; Wang S; Zhou S; Du S; Zheng L; Wang X; Wang H; Wang Y; Gao M
    Front Genet; 2023; 14():1126555. PubMed ID: 37025448
    [No Abstract]   [Full Text] [Related]  

  • 12. Choroidal abnormalities in café-au-lait syndromes: a new differential diagnostic tool?
    Cassiman C; Casteels I; Jacob J; Plasschaert E; Brems H; Dubron K; Keer KV; Legius E
    Clin Genet; 2017 Apr; 91(4):529-535. PubMed ID: 27716896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
    Marque M; Roubertie A; Jaussent A; Carneiro M; Meunier L; Guillot B; Pinson L; Pinson S; Bessis D
    J Am Acad Dermatol; 2013 Nov; 69(5):768-775. PubMed ID: 23972508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
    Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
    J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Piebaldism with Café-au-Lait Macules.
    Kansal NK; Agarwal S
    Skinmed; 2017; 15(3):223-225. PubMed ID: 28705289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple or familial café-au-lait spots is neurofibromatosis type 6: clarification of a diagnosis.
    Madson JG
    Dermatol Online J; 2012 May; 18(5):4. PubMed ID: 22630574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Café-au-lait macules overlying segmental macular hyperpigmentation in a pediatric patient: an early sign for mosaic neurofibromatosis type 1.
    Zhang J; Qin W; Hua S; Li M; Tang Y; Yao Z
    Br J Dermatol; 2020 Oct; ():. PubMed ID: 33113159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legius Syndrome and its Relationship with Neurofibromatosis Type 1.
    Denayer E; Legius E
    Acta Derm Venereol; 2020 Mar; 100(7):adv00093. PubMed ID: 32147744
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.